Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies. | Cell Death Discov | 2025 | 40804253 | PubTator, text mining | PubMed |
| An ancient enhancer rapidly evolving in the human lineage promotes neural development and cognitive flexibility. | Sci Adv | 2025 | 40802760 | PubTator, text mining | PubMed |
| Atypical cytoplasmic inclusions and erythrophagocytosis in acute myeloid leukemia with KMT2A::MLLT3 and U2AF1 mutation. | Blood | 2025 | 40773175 | PubTator, text mining | PubMed |
| RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications. | MedComm (2020) | 2025 | 40761481 | PubTator, text mining | PubMed |
| A clinico-genomic prognostic model for primary myelodysplastic neoplasm in Asia. | Blood Cancer J | 2025 | 40745181 | PubTator, text mining | PubMed |
| Regulation and intervention of stem cell differentiation by long non-coding RNAs: Mechanisms and therapeutic potential. | World J Stem Cells | 2025 | 40740526 | PubTator, text mining | PubMed |
| A molecular-based risk score for predicting leukemia-free survival in adult AML patients undergoing Allo-HSCT. | iScience | 2025 | 40740489 | PubTator, text mining | PubMed |
| Bovine lactoferrin drives cell cycle arrest and alters the transcriptomic profile of NSCLC cells. | Sci Rep | 2025 | 40738980 | PubTator, text mining | PubMed |
| Welander distal myopathy-associated TIA1 mutation exacerbates P-body and stress granule dynamics concomitant with nucleolar stress under oxidative stress. | Genes Dis | 2025 | 40735695 | PubTator, text mining | PubMed |
| TET dioxygenases localize at splicing speckles and promote RNA splicing. | Nucleus | 2025 | 40717330 | PubTator, text mining | PubMed |
| Aberrant splicing of CHEK1 is a driver of megakaryocytic dysplasia in U2AF1S34F mutant myelodysplastic neoplasms. | Leukemia | 2025 | 40652060 | PubTator, text mining | PubMed |
| CSF3R mutations and variants in myeloid neoplasms: associated phenotypes, co-mutations, and survival trends. | Haematologica | 2025 | 40637773 | PubTator, text mining | PubMed |
| CHIC: A machine learning framework for inferring the presence of high-risk clonal hematopoiesis using complete blood count data from 431,531 UK Biobank participants. | Hemasphere | 2025 | 40620734 | PubTator, text mining | PubMed |
| Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab. | Ther Adv Hematol | 2025 | 40546817 | PubTator, text mining | PubMed |
| Impact of ETV6 mutations on clinical outcomes in acute myeloid leukemia: a real-world retrospective cohort study. | Ann Hematol | 2025 | 40542832 | PubTator, text mining | PubMed |
| Prognostic impact of somatic mutations and additional chromosomal abnormalities in patients with myelodysplastic syndromes and chromosome 20q deletion. | Clin Exp Med | 2025 | 40512417 | PubTator, text mining | PubMed |
| Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms. | Transl Oncol | 2025 | 40494174 | PubTator, text mining | PubMed |
| Analysis of the differences in immune indexes of common gene mutations and 5q- chromosome karyotype mutations in MDS. | Discov Oncol | 2025 | 40488910 | PubTator, text mining | PubMed |
| Multipurpose RNA maturation factors dysregulate multiple mRNA processing steps simultaneously and provide new therapeutic opportunities. | RNA Biol | 2025 | 40485569 | PubTator, text mining | PubMed |
| Identification of substrates and sequence requirements for CARNMT1-mediated histidine methylation of C3H zinc fingers. | J Biol Chem | 2025 | 40473212 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=7